Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANT-1207 in Acne
NCT01293552Phase 2Completed
- Sponsor
- Anterios, Inc.
- Start
- Jan 2011
- Primary completion
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in acne vulgaris, sponsored by Anterios, Inc.. Started Jan 2011; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01293552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01293552.